The IDSA Center for Global Health Policy and the HIV Medicine Association released a policy statement on the results of HPTN 052 with recommendations for U.S. global and domestic AIDS Policy. Entitled “U.S. Policy and Funding on AIDS Should Follow the Science,” the statement recommends that a larger share of the PEPFAR budget be devoted […]
The following is a blog post by Kristen Jill Kresge of the International AIDS Vaccine Initiative. Writing from the AIDS Vaccine Conference in Bangkok, Thailand, Kresge provides a synopsis of the first plenary session of the conference. The post was originally published on IAVIReport. At the first plenary session of AIDS Vaccine 2011, which opened this […]
The following is a blog post by Jose Esparza, Deputy Director of HIV Vaccines at the Bill and Melinda Gates Foundation. Writing from the AIDS Vaccine Conference in Bangkok, Thailand, Dr. Esparza discusses recent scientific developments in the creation of an AIDS vaccine, and what we can expect to see in the future. The post […]
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]